| Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis MM Mücke, LI Backus, VT Mücke, N Coppola, CM Preda, ML Yeh, ... The Lancet Gastroenterology & Hepatology 3 (3), 172-180, 2018 | 188 | 2018 |
| Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication CF Huang, ML Yeh, PC Tsai, MH Hsieh, HL Yang, MY Hsieh, JF Yang, ... Journal of hepatology 61 (1), 67-74, 2014 | 148 | 2014 |
| Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan ML Yu, ML Yeh, PC Tsai, CI Huang, JF Huang, CF Huang, MH Hsieh, ... Medicine 94 (13), e690, 2015 | 113 | 2015 |
| Tenofovir versus entecavir for hepatocellular carcinoma prevention in an international consortium of chronic hepatitis B YC Hsu, GLH Wong, CH Chen, CY Peng, ML Yeh, KS Cheung, H Toyoda, ... Official journal of the American College of Gastroenterology| ACG 115 (2 …, 2020 | 93 | 2020 |
| Chronic hepatitis C infection is associated with insulin resistance and lipid profiles CY Dai, ML Yeh, CF Huang, CH Hou, MY Hsieh, JF Huang, IL Lin, ZY Lin, ... Journal of gastroenterology and hepatology 30 (5), 879-884, 2015 | 82 | 2015 |
| Real-world effectiveness from the Asia Pacific Rim Liver Consortium for HBV risk score for the prediction of hepatocellular carcinoma in chronic hepatitis B patients treated … HI Yang, ML Yeh, GL Wong, CY Peng, CH Chen, HN Trinh, KS Cheung, ... The Journal of infectious diseases 221 (3), 389-399, 2020 | 81 | 2020 |
| Association between fatty liver and cirrhosis, hepatocellular carcinoma, and hepatitis B surface antigen seroclearance in chronic hepatitis B J Li, HI Yang, ML Yeh, MH Le, AK Le, YH Yeo, CY Dai, S Barnett, ... The Journal of Infectious Diseases 224 (2), 294-302, 2021 | 76 | 2021 |
| Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection ML Yeh, CF Huang, CI Huang, JA Holmes, MH Hsieh, YS Tsai, PC Liang, ... Journal of hepatology 73 (1), 62-71, 2020 | 72 | 2020 |
| Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals ML Yeh, CF Huang, MH Hsieh, YM Ko, KY Chen, TW Liu, YH Lin, ... Journal of gastroenterology and hepatology 32 (10), 1754-1762, 2017 | 70 | 2017 |
| Incidences and determinants of functional cure during entecavir or tenofovir disoproxil fumarate for chronic hepatitis B YC Hsu, ML Yeh, GLH Wong, CH Chen, CY Peng, M Buti, M Enomoto, ... The Journal of infectious diseases 224 (11), 1890-1899, 2021 | 69 | 2021 |
| Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis JF Huang, PC Tsai, ML Yeh, CF Huang, CI Huang, MH Hsieh, CY Dai, ... Journal of the Formosan Medical Association 119 (1), 89-96, 2020 | 60 | 2020 |
| Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection MH Hsieh, JJ Tsai, MY Hsieh, CF Huang, ML Yeh, JF Yang, K Chang, ... PloS one 9 (4), e94791, 2014 | 56 | 2014 |
| Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan PC Tsai, HT Kuo, CH Hung, KC Tseng, HC Lai, CY Peng, JH Wang, ... Journal of hepatology 78 (2), 281-292, 2023 | 55 | 2023 |
| HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort Y Tanaka, E Ogawa, CF Huang, H Toyoda, DW Jun, CH Tseng, YC Hsu, ... Hepatology international 14, 1023-1033, 2020 | 55 | 2020 |
| High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients ML Yu, CY Dai, CF Huang, JJ Lee, ML Yeh, SM Yeh, HT Kuo, JF Huang, ... Journal of hepatology 60 (2), 253-259, 2014 | 52 | 2014 |
| Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection CY Dai, CY Lin, PC Tsai, PY Lin, ML Yeh, CF Huang, WT Chang, ... Journal of the Chinese Medical Association 81 (2), 155-163, 2018 | 51 | 2018 |
| Hepatitis C virus infection and metabolic syndrome—a community-based study in an endemic area of Taiwan JF Huang, WL Chuang, ML Yu, SH Yu, CF Huang, CI Huang, ML Yeh, ... The Kaohsiung journal of medical sciences 25 (6), 299-305, 2009 | 48 | 2009 |
| Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: a real‐world nationwide hepatitis C virus registry programme in Taiwan CY Chen, CF Huang, PN Cheng, KC Tseng, CC Lo, HT Kuo, YH Huang, ... Liver International 41 (6), 1265-1277, 2021 | 47 | 2021 |
| Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1 CF Huang, ML Yeh, JF Huang, JF Yang, MY Hsieh, ZY Lin, SC Chen, ... Antiviral research 93 (2), 239-244, 2012 | 47 | 2012 |
| Anti‐viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus‐related hepatocellular carcinoma: real‐world east and west … VL Chen, ML Yeh, AK Le, M Jun, WK Saeed, JD Yang, CF Huang, HY Lee, ... Alimentary pharmacology & therapeutics 48 (1), 44-54, 2018 | 46 | 2018 |
